Oncogene Expression & Isoform Profiling Service
The oncogene expression and isoform profiling service furnishes high-resolution, full-length transcriptome data utilizing advanced long-read sequencing (LRS) technology. Creative Biolabs is committed to delivering fully customized project designs, thereby ensuring that the platform and subsequent analysis are optimally aligned with unique research objectives. Clients receive actionable molecular insights, enabling confident identification of functional molecular drivers, effective de-risking of potential therapeutic targets, and the acceleration of preclinical research timelines by mitigating the uncertainty associated with fragmented short-read data.
Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Introduction of Oncogene Expression & Isoform Profiling Service
The oncogene expression and isoform profiling service is an indispensable resource for advancing contemporary oncology research, as it facilitates the transition from reliance on aggregated gene expression metrics to the rigorous functional analysis of alternative splicing mechanisms. This mechanism generates numerous protein variants (isoforms), often dictating disease phenotype, metastasis, and resistance. Our approach, validated by published data, resolves the issue of unreliable short-read data and computational inference by providing true full-length transcript structure. This depth allows researchers to identify novel oncogenic splice variants and understand the molecular switches driving therapeutic resistance with unparalleled clarity.
For an in-depth analysis of how our services can be tailored to your specific project needs, request a consultation.
Fig.1 Four platforms for isoform expression measurement. 1
What We Can Offer
Customization
Full flexibility in project design, from targeted panels focused on specific oncogene families to whole-transcriptome discovery in bulk tissue or single cells, all customized to your research goals.
One-Stop Service
Comprehensive support from sample qualification through to translational scientific reporting, ensuring a seamless path from raw sample to actionable molecular insight.
Rigorous Quality System (QbD)
Well-established quality assurance throughout the process, including robust QC tools used to quantify and evaluate the stability and reproducibility of all isoform expression metrics.
Advanced Process Development
Efficient upstream (library preparation) and downstream (bioinformatic analysis) process development optimized to maximize the detection yield of novel and low-abundance functional isoforms.
How Creative Biolabs Can Help
Highlights
Definitive Structural Clarity
The service delivers the true, full-length transcript sequence, resolving issues such as computational inference bias and platform inconsistency inherent to conventional short-read sequencing methods.
Novel Target Discovery
High-depth sequencing routinely identifies tens of thousands of previously unannotated isoforms, substantially expanding the repertoire of potential targets beyond known canonical gene products.
De-risking Drug Development
Validation of the dominant, functional target isoform prevents the costly pursuit of targets based on misleading bulk expression data, which may be significantly overestimated.
Cellular Resolution
Cell-type-specific isoform usage is resolved, which is critical for fully elucidating tumor microenvironment heterogeneity and the molecular mechanisms underlying metastasis.
To fully understand the Creative Biolabs advantage, we invite you to get a quote today.
Customer Reviews
-
Reliable Quantification
The precise, quantitative isoform usage data furnished by Creative Biolabs significantly advanced our research concerning the TGF-β pathway. This analysis enabled the resolution of cell-type-specific splicing shifts driving cancer-associated fibroblast formation, which were entirely obscured by the inconsistent data generated from our previous short-read vendor. - Dr. K*e.
-
Validation Speed
The comprehensive reporting and structural clarity achieved through Creative Biolabs' full-length sequencing methodology facilitated the validation of our primary antibody target against the correct, dominant splice variant in approximately half the projected timeframe, thus substantially accelerating our preclinical pipeline. - P*a Z**g.
FAQs
Why is your LRS approach superior to standard short-read RNA-seq for isoform profiling?
Standard RNA-seq relies on computationally stitching together short fragments to infer the full transcript structure, leading to high error rates and poor consistency. Creative Biolabs' LRS measures the full-length cDNA molecule directly, eliminating the need for inference and providing definitive, end-to-end structural and quantitative accuracy.
Can Creative Biolabs' service distinguish between isoforms in different cell types within a heterogeneous tumor sample?
Yes. We offer high-throughput single-cell LRS, which provides the necessary resolution to map specific isoform usage (including novel variants) to defined cell populations, such as tumor cells, immune cells, or cancer-associated fibroblasts.
Related Services
Metabolite Profiling Service
Comprehensive analysis of the metabolic landscape influenced by the expression of key oncogenic isoforms, providing orthogonal data for mechanism of action studies.
Learn More →
Genome-scale In Vivo Screening Service
Large-scale in vivo screening using CRISPR or shRNA libraries to systematically validate the essentiality and functional relevance of identified oncogenic splice variants in translational animal models.
Learn More →
How to Contact Us
Creative Biolabs translates the complex world of alternative splicing into clear, actionable molecular insights, moving you beyond the limitations of bulk genomics and accelerating the path to next-generation oncology therapeutics. To initiate discussion concerning specific project requirements, sample specifications, or to formally request a detailed quotation, please contact our expert team for professional assistance.
Reference
-
Zhang, Wei et al. "A large-scale comparative study of isoform expressions measured on four platforms." BMC genomics vol. 21,1 272. 30 Mar. 2020. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1186/s12864-020-6643-8
For Research Use Only | Not For Clinical Use
Download our brochure